These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 65605

  • 1. High remission-induction rate in acute myeloid leukaemia.
    Gale RP, Cline MJ.
    Lancet; 1977 Mar 05; 1(8010):497-9. PubMed ID: 65605
    [Abstract] [Full Text] [Related]

  • 2. [Comparison of the effects of cytosine arabinoside, cytosine arabinoside and thioguanine, and cytosine arabinoside and daunorubicin in acute myeloid leukemia].
    Malpas J, Mathé G, Hayat M.
    Bull Cancer; 1974 Mar 05; 61(3):411-8. PubMed ID: 4533741
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A second comparative trial of remission induction (by cytosine arabinoside given every 12 hours, or C.A.R. and thioguanine, or C.A.R. and daunorubicine) and maintenance therapy (by C.A.R. or methylgag) in acute myeloid leukaemia.
    Eur J Cancer (1965); 1974 Jul 05; 10(7):413-8. PubMed ID: 4532961
    [No Abstract] [Full Text] [Related]

  • 6. A comparative trial of remission induction (by cytosine arabinoside, or C.A.R. and thioguanine, or C.A.R. and daunorubicine) and maintenance therapy (by C.A.R. or methylgag) in acute myeloid leukaemia.
    Biomedicine; 1973 May 05; 18(3):192-8. PubMed ID: 4517790
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Adult acute leukaemia.
    Atkinson K, Wells DG, Clink HM, Kay HE, Powles R, McElwain TJ.
    Br J Cancer; 1974 Sep 05; 30(3):272-8. PubMed ID: 4141625
    [Abstract] [Full Text] [Related]

  • 11. Comparative study of cytosine arabinoside therapy alone and combined with thioguanine, mercaptopurine, or daunorubicin in acute myelocytic leukemia.
    Carey RW, Ribas-Mundo M, Ellison RR, Glidewell O, Lee ST, Cuttner J, Levy RN, Silver R, Blom J, Haurani F, Spurr CL, Harley JB, Kyle R, Moon JH, Eagan RT, Holland JH.
    Cancer; 1975 Nov 05; 36(5):1560-6. PubMed ID: 1059499
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. CPX-351 versus 7+3 cytarabine and daunorubicin chemotherapy in older adults with newly diagnosed high-risk or secondary acute myeloid leukaemia: 5-year results of a randomised, open-label, multicentre, phase 3 trial.
    Lancet JE, Uy GL, Newell LF, Lin TL, Ritchie EK, Stuart RK, Strickland SA, Hogge D, Solomon SR, Bixby DL, Kolitz JE, Schiller GJ, Wieduwilt MJ, Ryan DH, Faderl S, Cortes JE.
    Lancet Haematol; 2021 Jul 05; 8(7):e481-e491. PubMed ID: 34171279
    [Abstract] [Full Text] [Related]

  • 14. D.A.T. (daunorubicin, cytarabine, 6-thioguanine) in acute myeloid leukaemia.
    Rees JK, Hayhoe FG.
    Lancet; 1978 Jun 24; 1(8078):1360-1. PubMed ID: 78123
    [No Abstract] [Full Text] [Related]

  • 15. Etoposide in remission induction of adult acute myeloid leukemia.
    Leoni F, Ciolli S, Patriarchi S, Morfini M, Rossi Ferrini P.
    Acta Haematol; 1990 Jun 24; 83(2):82-5. PubMed ID: 2106200
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Treatment of acute myeloid leukaemia according to the Hammersmith protocol: preliminary report.
    Paolino W, Resegotti L, Rossi M, Infelise V.
    Br Med J; 1973 Sep 15; 3(5880):567-8. PubMed ID: 4516626
    [Abstract] [Full Text] [Related]

  • 19. Treatment of acute myeloid leukaemia with daunorubicin, cytosine arabinoside, mercaptopurine, L-asparaginase, prednisone and thioguanine: results of treatment with five multiple-drug schedules. Report of the Medical Research Council's Working Party on Leukaemia in Adults.
    Br J Haematol; 1974 Jul 15; 27(3):373-89. PubMed ID: 4607313
    [No Abstract] [Full Text] [Related]

  • 20. Intensive timed sequential remission induction chemotherapy with high-dose cytarabine for childhood acute myeloid leukemia.
    Loeb DM, Bowers DC, Civin CI, Friedman AD.
    Med Pediatr Oncol; 2001 Oct 15; 37(4):365-71. PubMed ID: 11568900
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.